Immunotherapy is a modern approach to cancer treatment that uses a patient's own immune system to help fight tumors. It has made an incredible impact on treating cancers in many different organ ...
Pharmaceutical Technology on MSN
GSK sells liver disease drug candidate to Alfasigma for $690m
GSK’s linerixibat is currently under regulatory review in the US, Europe, and China, amongst other regions.
Add Yahoo as a preferred source to see more of our stories on Google. Most people have never heard of primary biliary cholangitis (PBC), but the progressive, rare cholestatic liver disease can cause ...
(A) The classic bile acid synthesis pathway: cholesterol 7α-hydroxylase (CYP7A1) converts cholesterol to 7α-hydroxycholesterol (7α-HOC). The sterol 12α-hydroxylase (CYP8B1) converts the intermediate ...
Diet plays an important role in preventing fatty liver. Here’s a list of seven foods recommended by a US-based ...
Salk Institute scientists discovered that bile acids in the liver can weaken immune cell function, making immunotherapy less effective against liver cancer. They pinpointed specific bile acids that ...
Gallstones comprise cholesterol stones, pigment stones and ‘mixed stones’, which are stones comprising different ratios of pigment and cholesterol. — Wikimedia Commons Gallstones are a common health ...
Researchers have identified a new axis of host defense by studying what happens during enteric infection -- a term that encompasses all types of intestinal infections including so called 'stomach flu.
Salk scientists discover that removing bile acid-creating protein BAAT and adding bile acid UDCA controls tumor growth in mice with liver cancer; UDCA dietary supplements may be quick solution to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results